跳至主要内容
临床试验/EUCTR2010-022496-66-GB
EUCTR2010-022496-66-GB进行中(未招募)不适用

An Evaluation of the Tolerability and Feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with Carmustine Wafers (Gliadel) in the Surgical Management of Primary Glioblastoma (GALA-5 Trial) - Feasibility of 5-ALA and Carmustine wafers for Glioblastoma (GALA-5)

Joint UCLH and UCL Biomedical Research Unit0 个研究点开始时间: 2011年1月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The patient is reviewed at a specialist neuro-oncology MDT. • Preop stealth MRI should be carried out on no or stable steroids according to RANO criteria • Imaging is evaluated by a neuro-radiologist and judged to have typical appearances of a primary GBM • Radical resection is judged to be realistic by the neurosurgeons at the MDT (i.e. NICE criteria for the use of Carmustine wafers can be met) • WHO performance status 0 or 1 • Age =18 • Patient judged by MDT to be fit for standard radical aggressive therapy for GBM (resection followed by RT with concomitant and adjuvant temozolomide)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • GBM thought to be transformed low grade or secondary disease • The patient has not been seen by a specialist MDT. • There is uncertainty about the radiological diagnosis • 5-ALA or Carmustine wafers is contra-indicated (inc known or suspected allergies to 5-ALA or porphyrins, or acute or chronic types of porphyria) • Pregnant or lactating women • Known or suspected HIV or other significant infection or comorbidity that would preclude radical aggressive therapy for GBM • Active liver disease (ALT or AST =5 x ULRR) • Concomitant anti-cancer therapy except steroids • History of other malignancies (except for adequately treated basal or squamous cell carcinoma or carcinoma in situ) within 5 years • Previous brain surgery (including biopsy) or cranial radiotherapy • Platelets <100 x10_9/L • Mini mental status score <15

研究者

发起方
Joint UCLH and UCL Biomedical Research Unit

相似试验

已完成
2 期
An evaluation of the tolerability and feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with carmustine wafers (Gliadel) in the surgical management of primary GlioblastomaTopic: National Cancer Research NetworkSubtopic: Brain TumourDisease: Brain and Nervous SystemCancer
ISRCTN77105850niversity College London (UK)120
已完成
不适用
A feasibility study to evaluate tolerability and physiological response tothe performance of exercises during short-arm centrifugation (SAHC) aspotential countermeasures for long-term space flightCompatibility of training exercises under artificial gravity generated by centrifugation
DRKS00021750DLR-Institut für Luft- und RaumfahrtmedizinInstitut für Luft- und RaumfahrtmedizinAbteilung Gravitationsbiologie12
尚未招募
Unknown
Safety and Efficacy of Glucagon-like peptide 1 agonists in dialysis patientsEnd stage kidney diseaseRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - DiabetesDiabetes
ACTRN12623000862640Auckland City Hospital95
进行中(未招募)
不适用
Evaluating the feasibility, acceptability and effectiveness of a school-based educator intervention to identify & support children with emotional and behavioural difficulties: a pilot randomised controlled trialEmotional difficultiesBehavioural difficultiesMental Health - AnxietyMental Health - Learning disabilitiesMental Health - Other mental health disordersNeurological - Other neurological disorders
ACTRN12621000652875Murdoch Children's Research Institute401
已完成
不适用
Evaluating the feasibility, acceptability and effectiveness of integrating mentalization principles into cognitive behavioural treatment for childhood anxiety disorders.Childhood Anxiety DisordersMental Health - Anxiety
ACTRN12622001068752Swinburne Univeristy of Technology22